Concerns are mounting among experts and government officials about the potential use of artificial intelligence (AI) to engineer synthetic viruses that could trigger deadly pandemics. Researchers warn that advances in AI technology may enable extremists or terrorists to design more potent pathogens that spread rapidly and resist current medical treatments.

The process involves creating a genetic blueprint of a harmful virus, which can then be synthesized through manmade DNA ordered from commercial laboratories. Although these labs typically conduct customer screenings to reduce risk, no legal mandate currently enforces such checks.

In response to these emerging threats, some executives from AI companies have urged policymakers in the United States to implement stricter regulations on the sale of synthetic DNA. They argue that modern AI systems have already surpassed the expertise of experienced virologists in designing viral structures, increasing concerns about misuse.

British national security and technology officials have also taken note of the risks, engaging in discussions about whether existing controls are adequate. The UK Government highlighted that it was the second country worldwide to issue official guidance on vetting buyers of synthetic DNA. A government spokesperson emphasized ongoing vigilance, stating that officials are “monitoring the risks closely” and continuously evaluating potential additional measures.

This debate comes amid broader scrutiny of how rapidly advancing biotechnology and AI intersect, raising difficult questions about balancing scientific innovation with biosecurity. As synthetic biology techniques become more accessible, governments may need to reconsider regulatory frameworks to address the growing possibility of genetically engineered biological threats.